Search

everythinglearnresearchcommunity

for

Search:↓

A new hydrogel with stem cells from human umbilical cords improves skin wound healing and reduces inflammation.

Skin has a larger surface area than thought, certain skin cells improve skin flap survival, better trials for skin conditions in children are needed, Stevens-Johnson syndrome rates vary by age and race, and better skin barrier function may reduce inflammation in the elderly.

Type 1/17 inflammation in psoriasis increases skin cell growth due to a molecule that could be a new treatment target.

γδTregs may help treat autoimmune diseases like alopecia areata by promoting hair regrowth and reducing immune attacks.

Understanding the genetics of alopecia areata could lead to better treatments.

COVID-19 vaccines have been linked to an increase in hair loss conditions.

Tafluprost could be a potential treatment for hair loss by promoting hair growth phase changes.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

Anti-IL-1 treatments might help with certain types of hair loss in people with high inflammation.

Targeting Interleukin-13 could help treat alopecia areata linked with atopic dermatitis.

Certain proteins are found at higher levels in balding areas compared to non-balding areas, suggesting a link to hair loss. This could be useful for diagnosing and treating hair loss.

Melanogenesis inhibitors like kojic acid and niacinamide can reduce inflammation and pigment production in skin cells.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

Larger prostate size in older men may be linked to poorer semen quality and fertility issues.

IL-15 promotes hair growth and protects hair follicles.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

IL-17 and certain immune cells are linked to more severe alopecia areata.

IL-24 contributes to skin aging by increasing collagen-degrading enzymes and decreasing collagen production when exposed to air pollution.

Scientists can control how skin stem cells divide by using different treatments.

Collagen VII helps skin heal and stay strong, sirolimus may lower skin cancer risk in kidney transplant patients, high-molecular-mass hyaluronan helps naked mole rats resist cancer, dermal γδ T cells aid in hair growth in rodents, and overexpression of IL-33 in mouse skin causes itchiness, offering a model for studying allergic inflammation treatments.

Alopecia Areata is an autoimmune disease causing hair loss in patches, often starting before age 20, and while some cases recover on their own, treatments include topical corticosteroids, minoxidil, and promising new methods like IL-31 antibodies and 308-nm Excimer laser therapy.

Exosomes from certain stem cells can fight hair loss by promoting hair growth and maintaining the growth phase of hair.

The new recombinant human collagen can help slow skin aging and repair skin, while also controlling inflammation.

Targeting IL-17 could help treat pattern hair loss.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

IL-17 inhibitors for psoriasis may cause unexpected hair loss.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

There is no cure for alopecia areata, but treatments like JAK inhibitors show promise.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.